READ: Featured Drug Insights: July 2025 - Prime Therapeutics
READ: Featured Drug Insights: July 2025
Your source for all Prime Therapeutics' June 2025 Drug Insights publications.
Prime Therapeutics (Prime) provides you with regular updates on the drug pipeline as well as next-generation clinical information and hot topics. The following Drug Insights publications for July 2025 will keep you informed on what’s trending now and trending clinical topics.
Released July 3, 2025
Providing a clinical deep dive into a select high-cost drug in the pipeline, this month's profile features Rebisufligene etisparvovec (UX111), an in vivo gene therapy to help treat patients with Sanfilippo A syndrome.
Looking for previous 2025 drug insights publications?
Simply click on the month to access past editions of our drug insights.
All brand names are property of their respective owners.